Consequences of the 340B drug pricing program

New England Journal of Medicine

Volumn 378, Issue 6, 2018, Pages 539-548

  Desai, Sunita ^a,b   McWilliams, J Michael ^b,c  

^a NEW YORK UNIVERSITY   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; DRUG COST; DRUG USE; HEALTH PROGRAM; HEMATOLOGIST; HUMAN; LOWEST INCOME GROUP; MEDICAID; MEDICARE; MORTALITY; ONCOLOGIST; OPHTHALMOLOGIST; OUTPATIENT CARE; PATIENT CARE; PRIORITY JOURNAL; PROGRAM EVALUATION; REIMBURSEMENT; RHEUMATOLOGIST; COST; ECONOMICS; EPIDEMIOLOGY; HEALTH ECONOMICS; HEMATOLOGY; HOSPITAL; HOSPITAL ORGANIZATION; ONCOLOGY; OPHTHALMOLOGY; ORGANIZATION AND MANAGEMENT; POVERTY; SAFETY NET HOSPITAL; STATISTICS AND NUMERICAL DATA; UNITED STATES;

COSTS AND COST ANALYSIS; DRUG COSTS; ECONOMICS, HOSPITAL; HEMATOLOGY; HOSPITAL-PHYSICIAN JOINT VENTURES; HOSPITALS; HUMANS; MEDICAL ONCOLOGY; MEDICARE PART B; MORTALITY; OPHTHALMOLOGY; OWNERSHIP; POVERTY; REIMBURSEMENT MECHANISMS; SAFETY-NET PROVIDERS; UNITED STATES;

EID: 85042100759     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMsa1706475     Document Type: Article

References (31)

1. Public Health Service Act, 42 U. S. C. § 256b.
2. Mulcahy AW, Armstrong C, Lewis J, Mattke S. The 340B prescription drug discount program: origins, implementation, and post-reform future. Santa Monica, CA: R A ND, 2014.
3. 340B drug pricing program. Rockville, MD: Health Resources & Services Administration, November 2017 (https://www.hrsa.gov/opa/).
4. Overview of the 340B drug pricing program. Washington, DC: 340B Health (http://www.340bhealth.org/340b-resources/340b-program/over view/).
5. Report to the Congress: overview of the 340B drug pricing program. Washington, DC: Medicare Payment Advisory Commission, May 2015 (http://www.medpac.gov/docs/default-source/reports/may-2015-report-to-the-congress-overview-of-the-340b-drug-pricing-program.pdf?sfvrsn=0).
6. Conti RM, Bach PB. The 340B drug discount program: hospitals generate profits by expanding to reach more affluent communities. Health Aff (Millwood) 2014;33:1786-92.
7. Drug pricing: manufacturer discounts in the 340B program offer benefits, but federal oversight needs improvement. Washington, DC: Government Accountability Office, September 2011 (http://www.gao.gov/assets/330/323702.pdf).
8. Conti RM, Bach PB. Cost consequences of the 340B drug discount program. JAMA 2013;309:1995-6.
9. Public Health Service. Notice regarding Section 602 of the Veterans Health Care Act of 1992 Outpatient Hospital Facilities: final notice. Federal Register. September 19, 1994:47884-6 (https://www.hrsa.gov/sites/default/files/opa/program requirements/federalregisternotices/out patienthospitalfacilities091994.pdf).
10. 340B hot topics: Office of Pharmacy Affairs update. Rockville, MD: Health Resources & Services Administration, 2017 (http://www.hrsa.gov/opa/updates/august 2014.html).
11. Hospital ownership of physician pract ices. Washington, DC: Department of Health and Human Services, Office of the Inspector General, September 1999 (https://oig.hhs.gov/oei/reports/oei-05-98-00110.pdf).
12. Lee DS, Lemieux T. Regression discontinuity designs in economics. J Econ Lit 2010;48:281-355.
13. Venkataramani AS, Bor J, Jena AB. Regression discontinuity designs in healthcare research. BMJ 2016;352:i1216.
14. Medicare Disproportionate Share Hospital fact sheet. Baltimore: Centers for Medicare & Medicaid Services, September 2017 (https://www.cms.gov/Outreach-and-Education/Medicare-Learning-Network-MLN/MLNProducts/downloads/Disproportionate-Share-Hospital.pdf).
15. Part B drug payment policy issues. In: Report to the Congress: Medicare and the health care delivery system. Washington, DC: Medicare Payment Advisory Commission, June 2015 (http://www.medpac.gov/docs/defau lt-source/repor t s/chapt er-3-pa rt-b-drug-payment-policy-issues-june-2015-report-.pdf?sfvrsn=0).
16. 340B Eligibility and registration: eligible organizations. Rockville, MD: Health Resources & Services Administration (https://www.hrsa.gov/opa/eligibility-and-registration/index.html).
17. Neprash HT, Chernew ME, Hicks AL, Gibson T, McWilliams JM. Association of financial integration between physicians and hospitals with commercial health care prices. JAMA Intern Med 2015;175:1932-9.
18. Sheingold S, Marchetti-Bowick E, Nguyen N, Yabroff KR. Medicare Part B drugs: pricing and incentives. Washington, DC: Department of Health and Human Services, March 8, 2016 (https://aspe.hhs.gov/system/files/pdf/187581/PartBDrug.pdf).
19. Clark BL, Hou J, Chou CH, Huang ES, Conti R. The 340B discount program: outpatient prescription dispensing patterns through contract pharmacies in 2012. Health Aff (Millwood) 2014;33:2012-7.
20. Sankoh AJ, Huque MF, Dubey SD. Some comments on frequently used multiple endpoint adjustment methods in clinical trials. Stat Med 1997;16:2529-42.
21. Barreca AI, Lindo JM, Waddell GR. Heaping-induced bias in regression-discontinuity designs. Econ Inq 2016;54:268-93.
22. Wooldridge JM. Econometric analysis of cross section and panel data. Vol. 58. Cambridge, MA: MIT Press, 2002.
23. Medicare.gov. Medicare 2017 and 2018 costs at a glance (https://www.medicare.gov/your-medicare-costs/costs-at-a-glance/costs-at-glance.html).
24. HHS Secretary Price: Trump administration is taking action on drug prices. Press release of the Department of Health and Human Services, July 13, 2017 (https://www.hhs.gov/about/news/2017/07/13/hhs-secretary-price-trump-administration-taking-action-drug-prices.html).
25. Baker LC, Bundorf MK, Kessler DP. Vertical integration: hospital ownership of physician practices is associated with higher prices and spending. Health Aff (Millwood) 2014;33:756-63.
26. Conti RM, Landrum MB, Jacobson M. The impact of provider consolidation on outpatient prescription drug-based cancer care spending. Washington, DC: Health Care Cost Institute, 2016 (http://www.healthcostinstitute.org/files/HCCI-Issue-Brief-Impact-of-Provider-Consolidation. pdf).
27. Koch TG, Wendling BW, Wilson NE. How vertical integration affects the quantity and cost of care for Medicare beneficiaries. J Health Econ 2017;52:19-32.
28. Scott KW, Orav EJ, Cutler DM, Jha AK. Changes in hospital-physician affiliations in U. S. hospitals and their effect on quality of care. Ann Intern Med 2017;166:1-8.
29. Song Z, Wallace J, Neprash HT, McKellar MR, Chernew ME, McWilliams JM. Medicare fee cuts and cardiologist-hospital integration. JAMA Intern Med 2015;175:1229-31.
30. Dranove D, Ody C. Employed for higher pay? How Medicare facility fees affect hospital employment of physicians. Evanston, IL: Kellogg School of Management, Northwestern University, 2016 (http://www.kellogg.northwestern. edu/faculty/publication-detail.aspx?id=be3b359c-e31a-11e6-9fbb-0050569b3e41).
31. Provider consolidation: the role of Medicare policy. In: Report to the Congress: Medicare and the health care delivery system. Washington, DC: Medicare Payment Advisory Commission, 2017 (http://www.medpac.gov/docs/default-source/reports/jun17-ch10.pdf?sfvrsn=0).